150 related articles for article (PubMed ID: 6323418)
1. Effect of plasma concentrations of uridine on pyrimidine biosynthesis in cultured L1210 cells.
Karle JM; Anderson LW; Cysyk RL
J Biol Chem; 1984 Jan; 259(1):67-72. PubMed ID: 6323418
[TBL] [Abstract][Full Text] [Related]
2. Uracil nucleotide synthesis in a human breast cancer cell line (MCF-7) and in two drug-resistant sublines that contain increased levels of enzymes of the de novo pyrimidine pathway.
Karle JM; Cowan KH; Chisena CA; Cysyk RL
Mol Pharmacol; 1986 Aug; 30(2):136-41. PubMed ID: 2874477
[TBL] [Abstract][Full Text] [Related]
3. Regulation of pyrimidine biosynthesis in cultured L1210 cells by 3-deazauridine.
Karle JM; Cysyk RL
Biochem Pharmacol; 1984 Dec; 33(23):3739-42. PubMed ID: 6095859
[TBL] [Abstract][Full Text] [Related]
4. Flux through the de novo pyrimidine pathway in vivo. Effect of N-phosphonacetyl-L-aspartate, a potent inhibitor of aspartate transcarbamylase.
Monks A; Anderson LW; Strong J; Cysyk RL
J Biol Chem; 1983 Nov; 258(22):13564-9. PubMed ID: 6417130
[TBL] [Abstract][Full Text] [Related]
5. Influence of ammonium ions on hepatic de novo pyrimidine biosynthesis.
Monks A; Chisena CA; Cysyk RL
Arch Biochem Biophys; 1985 Jan; 236(1):1-10. PubMed ID: 2981502
[TBL] [Abstract][Full Text] [Related]
6. Effect of inhibitors of the de novo pyrimidine biosynthetic pathway on serum uridine levels in mice.
Karle JM; Anderson LW; Dietrick DD; Cysyk RL
Cancer Res; 1981 Dec; 41(12 Pt 1):4952-5. PubMed ID: 6171344
[TBL] [Abstract][Full Text] [Related]
7. Selective inhibition of pyrimidine synthesis and depletion of nucleotide pools by N-(phosphonacetyl)-L-aspartate.
Moyer JD; Handschumacher RE
Cancer Res; 1979 Aug; 39(8):3089-94. PubMed ID: 455293
[No Abstract] [Full Text] [Related]
8. A 13C tracer method for quantitating de novo pyrimidine biosynthesis in vitro and in vivo.
Strong JM; Anderson LW; Monks A; Chisena CA; Cysyk RL
Anal Biochem; 1983 Jul; 132(2):243-53. PubMed ID: 6414331
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effects with inhibitors of de novo pyrimidine synthesis, acivicin, and N-(phosphonacetyl)-L-aspartic acid.
Loh E; Kufe DW
Cancer Res; 1981 Sep; 41(9 Pt 1):3419-23. PubMed ID: 7260907
[TBL] [Abstract][Full Text] [Related]
10. Cyclopentenyl uracil: an effective inhibitor of uridine salvage in vivo.
Cysyk RL; Malinowski N; Marquez V; Zaharevitz D; August EM; Moyer JD
Biochem Pharmacol; 1995 Jan; 49(2):203-7. PubMed ID: 7840797
[TBL] [Abstract][Full Text] [Related]
11. Uridine and cytidine metabolism following inhibition of de novo pyrimidine synthesis by pyrazofurin.
Cadman E; Benz C
Biochim Biophys Acta; 1980 Oct; 609(3):372-82. PubMed ID: 7437431
[TBL] [Abstract][Full Text] [Related]
12. Salvage of circulating pyrimidine nucleosides in the rat.
Moyer JD; Oliver JT; Handschumacher RE
Cancer Res; 1981 Aug; 41(8):3010-7. PubMed ID: 7248957
[TBL] [Abstract][Full Text] [Related]
13. Biosynthesis and scavenging of pyrimidines by pathogenic mycobacteria.
Wheeler PR
J Gen Microbiol; 1990 Jan; 136(1):189-201. PubMed ID: 2191077
[TBL] [Abstract][Full Text] [Related]
14. Pyrimidine nucleosides enhance the efficacy of inhibitors of pyrimidine biosynthesis in cultured hepatocellular carcinoma cells.
Jacobsen LB; Putnam JE; Sawick DP; Cassady JM; Morré DJ
Life Sci; 1988; 42(8):913-8. PubMed ID: 3343891
[TBL] [Abstract][Full Text] [Related]
15. Kinetics of N-(phosphonacetyl)-L-aspartate and pyrazofurin depletion of pyrimidine ribonucleotide and deoxyribonucleotide pools and their relationship to nucleic acid synthesis in intact and permeabilized cells.
Moyer JD; Smith PA; Levy EJ; Handschumacher RE
Cancer Res; 1982 Nov; 42(11):4525-31. PubMed ID: 7127293
[TBL] [Abstract][Full Text] [Related]
16. Effect of deoxycytidine on the in vitro response of human leukemia cells to inhibitors of de novo pyrimidine biosynthesis.
Bhalla K; Grant S
Cancer Chemother Pharmacol; 1987; 19(3):226-32. PubMed ID: 3581416
[TBL] [Abstract][Full Text] [Related]
17. Effects of acivicin and dichloroallyl lawsone upon pyrimidine biosynthesis in mouse L1210 leukemia cells.
Kemp AJ; Lyons SD; Christopherson RI
J Biol Chem; 1986 Nov; 261(32):14891-5. PubMed ID: 3771555
[TBL] [Abstract][Full Text] [Related]
18. Control of pyrimidine biosynthesis in human lymphocytes. Inhibition of pyrimidine biosynthesis de novo in phytohemagglutinin-stimulated lymphocytes by external uridine and its inhibition mechanism.
Ito K; Uchino H
J Biol Chem; 1973 Jul; 248(13):4782-5. PubMed ID: 4718743
[No Abstract] [Full Text] [Related]
19. Contribution of de-novo and salvage synthesis to the uracil nucleotide pool in mouse tissues and tumors in vivo.
Zaharevitz DW; Anderson LW; Malinowski NM; Hyman R; Strong JM; Cysyk RL
Eur J Biochem; 1992 Nov; 210(1):293-6. PubMed ID: 1446677
[TBL] [Abstract][Full Text] [Related]
20. Uridylate-trapping sugar analogs in combination with inhibitors of uridylate synthesis de novo and 5-fluorouridine.
Keppler D; Fauler J; Gasser T; Holstege A; Leube K; Schulz-Holstege C; Weckbecker G
Adv Enzyme Regul; 1985; 23():61-79. PubMed ID: 2416194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
